Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve audited financial results for the year and quarter ended 31.03.2025 and to recommend final dividend if any and to transact other general matters as stated in the agenda

pdf

Fischer Medical Ventures Ltd.

16 May 2025

113.95

0.57%

Company Update

Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Fischer Medical Ventures Limited has informed the exchange on the receipt of Monitoring agency report for the quarter ended 31.03.2025

pdf

Fischer Medical Ventures Ltd.

05 May 2025

113.95

0.57%

AGM

Fischer Medical Ventures Ltd - 524743 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Fischer Medical Ventures Limited has informed the exchange on the outcome of Postal ballot and the scrutinizer report

pdf

Fischer Medical Ventures Ltd.

30 Apr 2025

113.95

0.57%

Corp. Note

Fischer Medical Ventures Ltd - 524743 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyFischer Medical Ventures Ltd 2CIN NO.L86900MH1993PLC288371 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: ARAVINDKUMAR VENKATASUBRAMANIAN Designation: COMPANY SECRETARY EmailId: cs@fischermv.com Name of the Chief Financial Officer: VIVEK BALASUBRAMANAN Designation: CHIEF FINANCIAL OFFICER EmailId: vivek.b@fischermv.com Date: 30/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf